"The suspension is a signal to countries that WHO, in compliance with the treatment guidelines, does not recommend countries procure the drug for COVID." WHO warns against its use on Covid patientsPrior to the suspension of remdesivir, WHO had warned against the use of Gilead's remdesivir on Covid-19 patients. "The ... panel found a lack of evidence that remdesivir improved outcomes that matter to patients," the WHO guideline said. 'Potential treatment' for coronavirus casesInitially, Gilead’s remdesivir was being touted as a potential treatment for cases of coronavirus for months. Dr Reddy's Laboratories, Zydus Cadila apart from Cipla and a few others were already making the generic remdesivir antiviral drug in the country.

Source: Mint November 21, 2020 03:33 UTC